• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Site-dependent response to chemotherapy for carcinoma of the breast.乳腺癌化疗的部位依赖性反应。
J R Soc Med. 1985;78 Suppl 9(Suppl 9):18-22.
2
Weekly docetaxel/paclitaxel in pretreated metastatic breast cancer.多西他赛/紫杉醇每周给药用于经治转移性乳腺癌
Clin Breast Cancer. 2002 Dec;3(5):346-52. doi: 10.3816/CBC.2002.n.038.
3
A phase II study of cisplatin and vinorelbine in patients with metastatic breast cancer.
Ann Oncol. 2002 Nov;13(11):1730-6. doi: 10.1093/annonc/mdf290.
4
Treatment with eribulin (halaven) in heavily pre-treated patients with metastatic breast cancer.
Acta Oncol. 2014 Sep;53(9):1275-7. doi: 10.3109/0284186X.2014.918277. Epub 2014 May 20.
5
Docetaxel plus cisplatin is effective for patients with metastatic breast cancer resistant to previous anthracycline treatment: a phase II clinical trial.多西他赛联合顺铂对先前蒽环类药物治疗耐药的转移性乳腺癌患者有效：一项II期临床试验。
BMC Cancer. 2005 Feb 22;5:21. doi: 10.1186/1471-2407-5-21.
6
[The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient].
Gan To Kagaku Ryoho. 1995 May;22(6):799-804.
7
Compassionate use of humanized anti-HER2/neu protein, trastuzumab for metastatic breast cancer in Japan.在日本，人性化抗HER2/neu蛋白曲妥珠单抗用于转移性乳腺癌的同情用药。
Breast Cancer. 2001;8(4):310-5. doi: 10.1007/BF02967530.
8
[Results of tamoxifen-medroxyprogesterone acetate sequential therapy in 22 patients with recurrent breast cancer].
Gan To Kagaku Ryoho. 1989 Nov;16(11):3555-8.
9
[A case report of advanced breast cancer with remarkable response to chemoendocrine therapy (CTF + MPA)].[一例晚期乳腺癌对化疗内分泌治疗（CTF + MPA）反应显著的病例报告]
Gan To Kagaku Ryoho. 1998 Apr;25(5):739-42.
10
[Clinical trial of UFT against disseminated breast cancer].
Gan To Kagaku Ryoho. 1984 Nov;11(11):2381-5.

引用本文的文献

1
Treating bony metastases.治疗骨转移瘤。
BMJ. 1991 Aug 24;303(6800):429-30. doi: 10.1136/bmj.303.6800.429.

本文引用的文献

1
Chemotherapy of metastatic carcinoma of the breast.
Clin Radiol. 1980 Jul;31(4):433-6. doi: 10.1016/s0009-9260(80)80184-x.
2
Prolonged remissions of metastatic breast cancer achieved with a six-drug regimen of relatively low toxicity.
Cancer. 1983 Jun 1;51(11):1998-2004. doi: 10.1002/1097-0142(19830601)51:11<1998::aid-cncr2820511107>3.0.co;2-u.
3
Randomized trial of cyclophosphamide, doxorubicin, and 5-fluorouracil alone or alternating with a "cycle active" non-cross-resistant combination in women with visceral metastatic breast cancer: a Southeastern Cancer Study Group project.环磷酰胺、阿霉素和5-氟尿嘧啶单独使用或与“周期活性”非交叉耐药联合方案交替使用治疗内脏转移性乳腺癌女性患者的随机试验：一项东南癌症研究组项目
J Clin Oncol. 1984 Jun;2(6):643-51. doi: 10.1200/JCO.1984.2.6.643.
4
Combination chemotherapy of metastatic breast carcinoma with cyclophosphamide, adriamycin, and peptichemio.环磷酰胺、阿霉素和派普化疗素联合治疗转移性乳腺癌
Cancer. 1984 May 1;53(9):1836-40. doi: 10.1002/1097-0142(19840501)53:9<1836::aid-cncr2820530906>3.0.co;2-p.
5
Sequential use of endocrine therapy and chemotherapy for metastatic breast cancer: effects on survival.内分泌治疗与化疗序贯用于转移性乳腺癌：对生存的影响
Cancer Treat Rep. 1980 Jan;64(1):111-6.
6
Cyclical combination chemotherapy for advanced breast carcinoma.晚期乳腺癌的周期性联合化疗
Br Med J. 1974 Feb 9;1(5901):218-20. doi: 10.1136/bmj.1.5901.218.
7
Proceedings: Superiority of adriamycin over oral nitrosoureas in patients with advanced breast carcinoma. A Southwest Cancer Chemotherapy study Group study.论文：阿霉素对晚期乳腺癌患者的疗效优于口服亚硝基脲。西南癌症化疗研究组的一项研究。
Cancer. 1974 Feb;33(2):519-26. doi: 10.1002/1097-0142(197402)33:2<519::aid-cncr2820330229>3.0.co;2-x.
8
Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer.
Cancer. 1975 Jul;36(1):90-7. doi: 10.1002/1097-0142(197507)36:1<90::aid-cncr2820360104>3.0.co;2-h.
9
An effective low-dose intermittent cyclophosphamide, methotrexate, and 5-fluorouracil treatment regimen for metastatic breast cancer.
Cancer. 1975 Apr;35(4):1101-7. doi: 10.1002/1097-0142(197504)35:4<1101::aid-cncr2820350413>3.0.co;2-m.
10
Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC 409962) and cyclophosphamide therapy of drug-resistant metastatic breast carcinoma.
Cancer. 1977 Sep;40(3):987-93. doi: 10.1002/1097-0142(197709)40:3<987::aid-cncr2820400304>3.0.co;2-0.

Site-dependent response to chemotherapy for carcinoma of the breast.

作者信息

Whitehouse J M

出版信息

J R Soc Med. 1985;78 Suppl 9(Suppl 9):18-22.

PMID:4045914
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1289529/
Abstract
摘要